In the second quarter of the fiscal year ending March 2027, profits declined significantly due to demand adjustments in the semiconductor-related business; however, robust performance in measurement and weighing instruments and medical & healthcare devices led to second-quarter cumulative sales and operating profit exceeding forecasts. The full-year forecast was revised upward with contributions from measurement and weighing instruments and medical & healthcare devices. Dividend policy remains unchanged. Order backlog shows an increasing trend year-over-year. By segment, semiconductor-related business in Japan declined, while medical & healthcare devices drove growth in the Americas and Europe.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7745","jir_company_name":"A&D HOLON Holdings Company, Limited","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/7745-20261106-02.pdf","jir_short_summary":"In the second quarter of the fiscal year ending March 2027, profits declined significantly due to demand adjustments in the semiconductor-related business; however, robust performance in measurement and weighing instruments and medical & healthcare devices led to second-quarter cumulative sales and operating profit exceeding forecasts. The full-year forecast was revised upward with contributions from measurement and weighing instruments and medical & healthcare devices. Dividend policy remains unchanged. Order backlog shows an increasing trend year-over-year. By segment, semiconductor-related business in Japan declined, while medical & healthcare devices drove growth in the Americas and Europe.","jir_summary":"### Overview of Results\nIn the second quarter of the fiscal year ending March 2027, the Company recorded a significant decline in profits due to demand adjustments in the semiconductor-related business. However, strong performance in the measurement and weighing instruments business and the medical & healthcare devices business led to second-quarter cumulative net sales and operating income exceeding forecasts. Order backlog increased year-over-year, indicating clearer signs of recovery in the semiconductor-related field. The full-year forecast has been revised upward assuming contributions from measurement and weighing instruments and medical & healthcare devices, with projected net sales of 70,000 million yen and operating income of 8,000 million yen.\n\n### Segment and Regional Trends and Outlook\nSemiconductor-related business in Japan continued to be affected by demand adjustments, resulting in decreased sales and profits. Measurement and weighing instruments remained solid, primarily in Japan. Medical & healthcare devices showed continued and expanding demand across all regions. In the Americas and Europe, medical & healthcare devices acted as growth drivers, and factors such as foreign exchange reimbursements contributed to profit improvement. The full-year outlook has been revised upward, but continued monitoring is necessary to achieve the fiscal year ending March 2027 targets.","jir_financial_highlights":"Net Sales: 30,172 million yen (Year-over-Year -0.7%)\nOperating Income: 2,178 million yen (Year-over-Year -31.0%)\nNet Income Attributable to Owners of Parent: 1,666 million yen (Year-over-Year -2.2%)\nFull-year Net Sales: 70,000 million yen (vs Initial Forecast +2.9%)\nFull-year Operating Income: 8,000 million yen (vs Initial Forecast +14.3%)\nFull-year Ordinary Income: 8,200 million yen (vs Initial Forecast +18.8%)\nEarnings Per Share: 60.84 yen (Year-over-Year Unknown)","jir_category":"","jir_hashtags":"#ShareBuyback, #EarningsRevision, #MeasurementAndWeighingInstruments, #MedicalDevices, #SemiconductorRelated, #MedicalAndHealthcareDevices","jir_key_figures":"Net Sales (Second Quarter Cumulative): 30,172 million yen\nOperating Income (Second Quarter Cumulative): 2,178 million yen\nFull-year Net Sales: 70,000 million yen\nFull-year Operating Income: 8,000 million yen\nEarnings Per Share: 60.84 yen","jir_meta_title":"A&D HOLON Holdings Company, Limited: Fiscal Year Ending March 2027 Q2 Financial Summary | Full-year Upward Revision","jir_meta_description":"Key points of A&D HOLON Holdings Company, Limited's Q2 results for the fiscal year ending March 2027. Summarizes segment trends, regional contributions, full-year forecast revisions, and order backlog status.","jir_og_title":"A&D HOLON Holdings Company, Limited: Q2 Financial Summary","jir_og_description":"Despite profit decline in semiconductor-related business, measurement & weighing instruments and medical & healthcare devices performed strongly. Full-year forecast revised upward, indicating future performance trends.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"26\/3\u671fQ2\\\",\\\"27\/3\u671fQ2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[{value:30000},{value:30172}]}]}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"26\/3\u671fQ2\\\",\\\"27\/3\u671fQ2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[{value:3156},{value:2178}]}]}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Semiconductor Related\\\",\\\"Measurement and Weighing Instruments\\\",\\\"Medical and Healthcare Devices\\\"],\\\"datasets\\\":[{\\\"data\\\":[1279, 14825, 13967]}]}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Operating Margin Analysis\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Semiconductor Related\\\",\\\"Measurement and Weighing Instruments\\\",\\\"Medical and Healthcare Devices\\\"],\\\"datasets\\\":[{\\\"data\\\":[-52.7, 24.8, 26.0]}]}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Full-year Forecast vs Actual\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Net Sales\\\",\\\"Operating Income\\\",\\\"Ordinary Income\\\"],\\\"datasets\\\":[{\\\"data\\\":[70300,8000,8200]},{\\\"data\\\":[70000,8000,8200]}]}\"}]","ir_related_company":17190,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-144162","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n